Patents by Inventor Manesh Dixit
Manesh Dixit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230158051Abstract: A pharmaceutical paste formulation containing an active ingredient, an API solubilizer, a cross-linking agent, a consistency improver, a rheology modifier, a humectant, and a liquid base.Type: ApplicationFiled: January 20, 2023Publication date: May 25, 2023Applicant: USpharma Ltd.Inventors: Manesh A Dixit, Partha S Sen, Rahul Botkar, Ashim K Sarkar
-
Patent number: 11633361Abstract: A product and process of manufacturing an edible soft-chewable dosage form for the delivery of pharmaceutically active ingredients or nutritional agents orally to an animal or human subject, by forming a granulated soft-chew mass by appropriate mixing and sifting steps, and forming tablets with a compression press. Such soft-chew dosage forms have hardness of less than about two kilopond (2 kp) and friability of less than about one percent (1%) at three-hundred (300) rotations when measured according to the United States Pharmacopeia (USP) test. The process for manufacturing such compressed soft-chew tablets employs compression (tablet) pressing equipment to produce soft-chew tablets of consistent weight and texture.Type: GrantFiled: June 5, 2020Date of Patent: April 25, 2023Assignee: First Time US Generics LLCInventors: Manesh A. Dixit, Vaibhav L. Pawar, Rushi R. Patel, Mineshkumar D. Patel, Amol Somwanshi
-
Patent number: 11590151Abstract: A pharmaceutical paste formulation containing an active ingredient, an API solubilizer, a cross-linking agent, a consistency improver, a rheology modifier, a humectant, and a liquid base.Type: GrantFiled: August 25, 2020Date of Patent: February 28, 2023Assignee: USPHARMA LTDInventors: Manesh A Dixit, Partha S Sen, Rahul Botkar, Ashim K Sarkar
-
Publication number: 20220409547Abstract: A product and process of manufacturing an edible soft-chewable dosage form for the delivery of pharmaceutically active ingredients or nutritional agents orally to an animal or human subject, by forming a granulated soft-chew mass by appropriate mixing and sifting steps, and forming tablets with a compression press. Such soft-chew dosage forms have hardness of less than about two kilopond (2 kp) and friability of less than about one percent (1%) at three-hundred (300) rotations when measured according to the United States Pharmacopeia (USP) test. The process for manufacturing such compressed soft-chew tablets employs compression (tablet) pressing equipment to produce soft-chew tablets of consistent weight and texture.Type: ApplicationFiled: August 23, 2022Publication date: December 29, 2022Applicant: First Time US Generics LLCInventors: Manesh A Dixit, Partha S Sen, Rahul G Raut
-
Publication number: 20220183970Abstract: One aspect of the present invention concerns compositions and methods of manufacturing translucent chewable gels that are pharmaceutically suitable for oral administration. The chewable gels includes an active pharmaceutical ingredient and a complexing agent. The active pharmaceutical ingredient has a bitter taste. The active pharmaceutical ingredient and the complexing agent are complexed in the form of an inclusion complex. The chewable gels are substantially devoid of bitter taste and/or a tendency to cause oral numbness when chewed.Type: ApplicationFiled: February 24, 2022Publication date: June 16, 2022Applicant: USpharma LtdInventors: Manesh A. Dixit, Rahul Botkar, Partha S. Sen
-
Patent number: 11273123Abstract: One aspect of the present invention concerns compositions and methods of manufacturing translucent chewable gels that are pharmaceutically suitable for oral administration. The chewable gels includes an active pharmaceutical ingredient and a complexing agent. The active pharmaceutical ingredient has a bitter taste. The active pharmaceutical ingredient and the complexing agent are complexed in the form of an inclusion complex. The chewable gels are substantially devoid of bitter taste and/or a tendency to cause oral numbness when chewed.Type: GrantFiled: July 18, 2019Date of Patent: March 15, 2022Assignee: USPHARMA LTDInventors: Manesh A Dixit, Rahul Botkar, Partha S Sen
-
Publication number: 20210060045Abstract: A pharmaceutical paste formulation containing an active ingredient, an API solubilizer, a cross-linking agent, a consistency improver, a rheology modifier, a humectant, and a liquid base.Type: ApplicationFiled: August 25, 2020Publication date: March 4, 2021Applicant: USpharma Ltd.Inventors: Manesh A. Dixit, Partha S. Sen, Rahul Botkar, Ashim K. Sarkar
-
Publication number: 20200297643Abstract: A product and process of manufacturing an edible soft-chewable dosage form for the delivery of pharmaceutically active ingredients or nutritional agents orally to an animal or human subject, by forming a granulated soft-chew mass by appropriate mixing and sifting steps, and forming tablets with a compression press. Such soft-chew dosage forms have hardness of less than about two kilopond (2 kp) and friability of less than about one percent (1%) at three-hundred (300) rotations when measured according to the United States Pharmacopeia (USP) test. The process for manufacturing such compressed soft-chew tablets employs compression (tablet) pressing equipment to produce soft-chew tablets of consistent weight and texture.Type: ApplicationFiled: June 5, 2020Publication date: September 24, 2020Applicant: First Time US Generics LLCInventors: Manesh A. DIXIT, Vaibhav L. PAWAR, Rushi R. Patel, Mineshkumar D. Patel, Amol SOMWANSHI
-
Publication number: 20200022909Abstract: One aspect of the present invention concerns compositions and methods of manufacturing translucent chewable gels that are pharmaceutically suitable for oral administration. The chewable gels includes an active pharmaceutical ingredient and a complexing agent. The active pharmaceutical ingredient has a bitter taste. The active pharmaceutical ingredient and the complexing agent are complexed in the form of an inclusion complex. The chewable gels are substantially devoid of bitter taste and/or a tendency to cause oral numbness when chewed.Type: ApplicationFiled: July 18, 2019Publication date: January 23, 2020Applicant: USpharma LtdInventors: Manesh A. Dixit, Rahul Botkar, Partha S. Sen
-
Publication number: 20190022013Abstract: A product and process of manufacturing an edible soft-chewable dosage form for the delivery of pharmaceutically active ingredients or nutritional agents orally to an animal or human subject, by forming a granulated soft-chew mass by appropriate mixing and sifting steps, and forming tablets with a compression press. Such soft-chew dosage forms have hardness of less than about two kilopond (2 kp) and friability of less than about one percent (1%) at three-hundred (300) rotations when measured according to the United States Pharmacopeia (USP) test. The process for manufacturing such compressed soft-chew tablets employs compression (tablet) pressing equipment to produce soft-chew tablets of consistent weight and texture.Type: ApplicationFiled: September 24, 2018Publication date: January 24, 2019Applicant: First Time US Generics LLCInventors: Manesh A. DIXIT, Vaibhav L. PAWAR, Rushi R. Patel, Mineshkumar D. Patel, Amol SOMWANSHI
-
Publication number: 20190000766Abstract: The present disclosure relates to oral, abuse deterrent, edible soft chewable dosage forms for delivery of drugs that are susceptible to abuse to a human or animal subject. The dosage forms are provided as chewable tablets manufactured using a compression (tablet) press. The edible soft chew dosage forms can be administered to subjects that are unable to swallow conventional tablets or capsules whole. One or more abuse deterrent measures in the dosage forms prevent the conversion of the dosage form into a residue or extract suitable for non-oral administration, such as intranasal or intravenous abuse. The present disclosure also relates to processes of preparing the dosage form. Such soft chew dosage forms have hardness less than 2 kilopond, preferably less than 1 kilopond, more preferably no measurable hardness when measured with tablet hardness tester and friability less than 1%, preferably less than 0.5%, more preferably less than 0.1% for 100 rotations (per USP); 200 rotations or 300 rotations.Type: ApplicationFiled: August 23, 2018Publication date: January 3, 2019Applicant: First Time US Generics LLCInventors: Manesh A. Dixit, Vaibhav Pawar, Rushi Patel, Mineshkumar Patel
-
Patent number: 10117831Abstract: A product and process of manufacturing an edible soft-chewable dosage form for the delivery of pharmaceutically active ingredients or nutritional agents orally to an animal or human subject, by forming a granulated soft-chew mass by appropriate mixing and sifting steps, and forming tablets with a compression press. Such soft-chew dosage forms have hardness of less than about 2 kilopond and friability of less than about 1% at 300 rotations (per USP). The process for manufacturing such compressed soft-chew tablets employs compression (tablet) pressing equipment to produce soft-chew tablets of consistent weight and texture.Type: GrantFiled: June 21, 2017Date of Patent: November 6, 2018Assignee: First Time US Generics LLCInventors: Manesh A. Dixit, Vaibhav L. Pawar, Rushi R. Patel, Mineshkumar D. Patel, Amol Somwanshi
-
Publication number: 20180169008Abstract: A product and process of manufacturing an edible soft-chewable dosage form for the delivery of pharmaceutically active ingredients or nutritional agents orally to an animal or human subject, by forming a granulated soft-chew mass by appropriate mixing and sifting steps, and forming tablets with a compression press. Such soft-chew dosage forms have hardness of less than about 2 kilopond and friability of less than about 1% at 300 rotations (per USP). The process for manufacturing such compressed soft-chew tablets employs compression (tablet) pressing equipment to produce soft-chew tablets of consistent weight and texture.Type: ApplicationFiled: June 21, 2017Publication date: June 21, 2018Inventors: Manesh A. DIXIT, Vaibhav L. PAWAR, Rushi R. PATEL, Mineshkumar D. PATEL, Amol SOMWANSHI
-
Patent number: 9468633Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.Type: GrantFiled: August 20, 2012Date of Patent: October 18, 2016Assignee: Andrx Pharmaceuticals, Inc.Inventors: Manesh Dixit, Chih-Ming Chen, Xiu Xiu Cheng, Jianbo Xie
-
Patent number: 8778395Abstract: A controlled release diltiazem dosage formulation comprising a plurality of diltiazem pellets and a gel-forming material where the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration and preferably more than 10 hours after administration.Type: GrantFiled: August 11, 2005Date of Patent: July 15, 2014Assignee: Andrx Labs, LLCInventors: Xiu Xiu Cheng, Xiaohong Qi, Guohua Zhang, Manesh Dixit
-
Patent number: 8668932Abstract: A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.Type: GrantFiled: March 18, 2011Date of Patent: March 11, 2014Assignee: Andrx Pharmaceuticals, LLCInventors: Manesh Dixit, Xiu-Xiu Cheng, Avinash Nangia, Chin Ming Chen
-
Publication number: 20130022678Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.Type: ApplicationFiled: August 20, 2012Publication date: January 24, 2013Applicant: ANDRX PHARMACEUTICALS, INC.Inventors: Manesh Dixit, Chih-Ming Chen, Xiu Xiu Cheng, Jianbo Xie
-
Patent number: 8252327Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.Type: GrantFiled: July 11, 2011Date of Patent: August 28, 2012Assignee: Andrx Pharmaceuticals, Inc.Inventors: Manesh Dixit, Chih-Ming Chen, Xiu-Xiu Cheng, Jianbo Xie
-
Publication number: 20110268799Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.Type: ApplicationFiled: July 11, 2011Publication date: November 3, 2011Applicant: ANDRX PHARMACEUTICALS, INC.Inventors: Manesh Dixit, Chih-Ming Chen, Xiu-Xiu Cheng, Jianbo Xie
-
Patent number: 7988993Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.Type: GrantFiled: December 2, 2003Date of Patent: August 2, 2011Assignee: Andrx Pharmaceuticals, Inc.Inventors: Manesh Dixit, Chih-Ming Chen, Xiu Xiu Cheng, Jianbo Xie